HBIO 10-Q: SEC filing
Harvard Bioscience
Filed with the SEC on · accession 0001171843-26-007336
HBIO filed a 10-Q (quarterly report) with the SEC on Nov 10, 2026. Harvard Bioscience filed its Q3 2026 Form 10-Q, reporting quarterly financial results including a reverse stock split effective March 2026 and restructuring activities. The stock moved +1.9% by the first close after the filing.
Summary of the filing
Harvard Bioscience filed its Q3 2026 Form 10-Q, reporting quarterly financial results including a reverse stock split effective March 2026 and restructuring activities. The filing reflects ongoing operational and financial developments for the period ended September 30, 2026.
Key details
How HBIO stock reacted
Close before
$9.09
Nov 9, 2026
First close after
+1.87%
$9.26
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for HBIO, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for HBIO?
Click hereFrequently asked questions
What did HBIO file with the SEC on Nov 10, 2026?
HBIO filed a 10-Q (SEC filing). Harvard Bioscience filed its Q3 2026 Form 10-Q, reporting quarterly financial results including a reverse stock split effective March 2026 and restructuring activities. The filing reflects ongoing operational and financial developments for the period ended September 30, 2026.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did HBIO stock react to this filing?
HBIO closed at $9.09 before the filing and $9.26 on Nov 10, 2026 (+1.87%).
Other HBIO SEC filings
Get alerts when HBIO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days